SCHEMBL23583314

SCHEMBL23583314

CN1CCN(C(C)(C)C)C(=S)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106424 0.73 POLB (0.33) —
SCHEMBL21324893 0.69 — —
SCHEMBL21627160 0.69 KDM4E (0.31) —
SCHEMBL24952528 0.67 — —
SCHEMBL23583265 0.62 MEN1 (0.33) —
SCHEMBL21324894 0.60 — —
SCHEMBL22751162 0.60 KDM4E (0.33) —
SCHEMBL9914394 0.59 — —
SCHEMBL611663 0.59 POLB (0.35) —
SCHEMBL13698409 0.59 POLB (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046684-B2 Compound for selectively inhibiting kinase and use thereof SHANGHAI ZHEYE BIOTECHNOLOGY LIMITED LIABILITY COMPANY (CN) 2021-06-29 — — US disclosed
Send feedback